Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver

Fitoterapia

Volumn 82, Issue 2, 2011, Pages 184-189

  Zhou, Ji Yin ^a   Zhou, Shi Wen ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant; Berberine; Diabetes; Lipid peroxidation; Liver tissue; Positive transcription elongation factor b

Indexed keywords

BERBERINE; CATALASE; CYCLIN DEPENDENT KINASE 9; CYCLIN T1; FENOFIBRATE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MESSENGER RNA; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; ROSIGLITAZONE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LIVER; LIVER PROTECTION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; UPREGULATION;

RATTUS;

EID: 79952362196     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2010.08.019     Document Type: Article

References (28)

1. Adeghate E, Schattner P, Dunn E. Ann NY Acad Sci 2006;1084:1.
2. Merkler M, Reiner Z. Fundam Clin Pharmacol 2007;21(Suppl 2):1.
3. Taleb-Senouci D, Ghomari H, Krouf D, Bouderbala S, Prost J, Lacaille-Dubois MA, et al. Phytomedicine 2009;16:623.
4. Kawano A, Nakamura H, Hata S, Minakawa M, Miura Y, Yagasaki K. Phytomedicine 2009;16:437.
5. Jung HA, Yoon NY, Bae HJ, Min BS, Choi JS. Arch Pharm Res 2008;31:1405.
6. Dynlacht BD. Nature 1997;389:149.
7. Jiang WL, Chen XG, Zhu HB, Hou J, Tian JW. Pharmacology 2009;84:162.
8. Hamdy NM, Taha RA. Pharmacology 2009;84:127.
9. Singh J, Kakkar P. J Ethnopharmacol 2009;123:22.
10. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, et al. Diabetes 2006;55:2256.
11. Yin J, Gao Z, Liu D, Liu Z, Ye J. Am J Physiol Endocrinol Metab 2008;294:E148.
12. Zhou L, Yang Y, Wang X, Liu S, Shang W, Yuan G, et al. Metabolism 2007;56:405.
13. Tang LQ, Wei W, Chen LM, Liu S. J Ethnopharmacol 2006;108:109.
14. Zhou J, Zhou S, Tang J, Zhang K, Guang L, Huang Y, et al. Eur J Pharmacol 2009;606:262.
15. Zhou JY, Zhou SW, Zhang KB, Tang JL, Guang LX, Ying Y, et al. Biol Pharm Bull 2008;31:1169.
16. Yin J, Xing H, Ye J. Metabolism 2008;57:712.
17. Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, et al. J Clin Endocrinol Metab 2008;93:2559.
18. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Pharmacol Res 2005;52:313.
19. Livak KJ, Schmittgen TD. Methods 2001;25:402.
20. Ajjan RA, Grant PJ. Expert Opin Drug Saf 2008;7:367.
21. Filippatos T, Milionis HJ. Expert Opin Investig Drugs 2008;17:1599.
22. Kamalakkannan N, Prince Stanely Mainzen P. Mol Cell Biochem 2006;293:211.
23. Yilmaz HR, Uz E, Yucel N, Altuntas I, Ozcelik N. J Biochem Mol Toxicol 2004;18:234.
24. Drewa G, Krzyzynska-Malinowska E, Wozniak A, Protas-Drozd F, Mila-Kierzenkowska C, Rozwodowska M, et al. Med Sci Monit 2002;8:BR338.
25. Herrman CE, Sanders RA, Klaunig JE, Schwarz LR, Watkins 3rd JB.Toxicol Sci 1999;50:146.
26. Marshall NF, Price DH. J Biol Chem 1995;270:12335.
27. Chao SH, Price DH. J Biol Chem 2001;276:31793.
28. Shim EY, Walker AK, Shi Y, Blackwell TK. Genes Dev 2002;16:2135.